| 27.71 -1.42 (-4.87%) | 10-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 34.7 |
1-year : | 37.15 |
| Resists | First : | 29.71 |
Second : | 31.8 |
| Pivot price | 29.1 |
|||
| Supports | First : | 26.32 |
Second : | 21.9 |
| MAs | MA(5) : | 28.68 |
MA(20) : | 29.1 |
| MA(100) : | 30.43  |
MA(250) : | 29.31 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 43.1 |
D(3) : | 47.2 |
| RSI | RSI(14): 44.2 |
|||
| 52-week | High : | 50.18 | Low : | 13.73 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HIMS ] has closed above bottom band by 13.5%. Bollinger Bands are 44.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 28.97 - 29.14 | 29.14 - 29.27 |
| Low: | 26.91 - 27.13 | 27.13 - 27.3 |
| Close: | 27.42 - 27.75 | 27.75 - 27.99 |
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Sun, 25 Oct 2026
3 ideas for this week: $CRCL, $HIMS, $SHOP ...all three have - KuCoin
Sun, 25 Oct 2026
HIMS EQUITY ACTION REMINDER Faruqi & Faruqi, LLP Reminds Hims (HI - The National Law Review
Fri, 23 Oct 2026
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors - Yahoo Finance
Fri, 23 Oct 2026
Hims & Hers Health (HIMS) Drops 5.3% to $27.57 - AlphaStreet
Fri, 23 Oct 2026
Hims & Hers Health Lobbying Profile, 2022 - OpenSecrets
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 225 (M) |
| Shares Float | 214 (M) |
| Held by Insiders | 4.9 (%) |
| Held by Institutions | 71.2 (%) |
| Shares Short | 54,770 (K) |
| Shares Short P.Month | 54,950 (K) |
| EPS | -0.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.38 |
| Profit Margin | -5.6 % |
| Operating Margin | -12.8 % |
| Return on Assets (ttm) | -2.3 % |
| Return on Equity (ttm) | -32.1 % |
| Qtrly Rev. Growth | 38.2 % |
| Gross Profit (p.s.) | 7.95 |
| Sales Per Share | 11.46 |
| EBITDA (p.s.) | -0.05 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 263 (M) |
| Levered Free Cash Flow | 849 (M) |
| PE Ratio | -43.3 |
| PEG Ratio | 2.5 |
| Price to Book value | 19.93 |
| Price to Sales | 2.41 |
| Price to Cash Flow | 23.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|